CN104876970A - 一种手性双噁唑啉钯配合物晶体及合成方法 - Google Patents
一种手性双噁唑啉钯配合物晶体及合成方法 Download PDFInfo
- Publication number
- CN104876970A CN104876970A CN201510258705.8A CN201510258705A CN104876970A CN 104876970 A CN104876970 A CN 104876970A CN 201510258705 A CN201510258705 A CN 201510258705A CN 104876970 A CN104876970 A CN 104876970A
- Authority
- CN
- China
- Prior art keywords
- reaction
- complex
- chlorobenzene
- bisoxazoline
- chiral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 239000013078 crystal Substances 0.000 title claims abstract description 14
- 229910052763 palladium Inorganic materials 0.000 title claims abstract description 5
- 238000001308 synthesis method Methods 0.000 title abstract 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 claims abstract description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims abstract description 9
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000003197 catalytic effect Effects 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 238000004440 column chromatography Methods 0.000 claims abstract description 5
- 239000000126 substance Substances 0.000 claims abstract description 5
- 238000005712 Baylis-Hillman reaction Methods 0.000 claims abstract description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960001701 chloroform Drugs 0.000 claims abstract description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000002825 nitriles Chemical class 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 7
- -1 phenyl aldehyde Chemical class 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- 238000010189 synthetic method Methods 0.000 claims description 5
- 230000009466 transformation Effects 0.000 claims description 4
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims description 3
- 235000005291 Rumex acetosa Nutrition 0.000 claims description 3
- 240000007001 Rumex acetosella Species 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 235000003513 sheep sorrel Nutrition 0.000 claims description 3
- 238000002447 crystallographic data Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 230000005260 alpha ray Effects 0.000 claims 1
- 229910002804 graphite Inorganic materials 0.000 claims 1
- 239000010439 graphite Substances 0.000 claims 1
- 125000006850 spacer group Chemical group 0.000 claims 1
- 238000010992 reflux Methods 0.000 abstract description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 abstract 2
- 238000006842 Henry reaction Methods 0.000 abstract 1
- BHXFKXOIODIUJO-UHFFFAOYSA-N benzene-1,4-dicarbonitrile Chemical compound N#CC1=CC=C(C#N)C=C1 BHXFKXOIODIUJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000012043 crude product Substances 0.000 abstract 1
- NWYYWIJOWOLJNR-RXMQYKEDSA-N l-valinol Chemical compound CC(C)[C@H](N)CO NWYYWIJOWOLJNR-RXMQYKEDSA-N 0.000 abstract 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 abstract 1
- 239000003208 petroleum Substances 0.000 abstract 1
- 239000011592 zinc chloride Substances 0.000 abstract 1
- 235000005074 zinc chloride Nutrition 0.000 abstract 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 6
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 125000002524 organometallic group Chemical group 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- XQZYPMVTSDWCCE-UHFFFAOYSA-N phthalonitrile Chemical class N#CC1=CC=CC=C1C#N XQZYPMVTSDWCCE-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- YNWSXIWHOSSPCO-UHFFFAOYSA-N rhodium(2+) Chemical class [Rh+2] YNWSXIWHOSSPCO-UHFFFAOYSA-N 0.000 description 1
- PZSJYEAHAINDJI-UHFFFAOYSA-N rhodium(3+) Chemical compound [Rh+3] PZSJYEAHAINDJI-UHFFFAOYSA-N 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/006—Palladium compounds
- C07F15/0066—Palladium compounds without a metal-carbon linkage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
- B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
- B01J31/184—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine mixed aromatic/aliphatic ring systems, e.g. indoline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Catalysts (AREA)
Abstract
一种手性双噁唑啉钯配合物,其化学式如下: (Ⅰ)。该手性配合物(I)的合成方法是由1,4-二氰基苯39.2mmol和L-缬氨醇16.2075g在无水无氧条件下和催化剂无水ZnCl2(26.4mol%)于氯苯溶剂中回流反应60小时,然后分离、纯化,反应结束后脱去氯苯,将粗产品用石油醚/二氯甲烷(4:1)柱层析,得白色噁唑啉晶体,再按照双噁唑啉与氯化钯摩尔比0.7:1,以氯苯为溶剂进行反应,用三氯甲烷、乙醇及正己烷进行重结晶,得红褐色双噁唑啉氯化钯配合物单晶。该手性配合物在苯甲醛的亨利反应、腈硅化反应及Baylis-Hillman反应中显示一定的催化性能,其转化率分别达67.1%,80.1%,36.2%。
Description
一、技术领域
本发明涉及一种金属有机配位化合物(配合物)及其合成方法,特别涉及含氮的手性金属有机配合物及用途,确切地说是一种手性双噁唑啉钯金属有机配合物晶体及其合成方法。
二、背景技术
随着有机化学的发展,金属有机化合物在有机合成中的应用愈来愈广,是现在有机化学中极为活跃的领域之一,已经广泛应用于有机合成反应中。20世纪60年代后期出现的使用手性配体与过渡金属络合物催化的不对称合成反应大大加速了手性药物的研究。化学催化不对称合成法的重要内容便是手性配体及含金属催化剂的设计,从而使反应具有高效和高对映选择性。近年来手性噁唑啉钯金属配合物在不对称催化领域取得了一定的催化效果。
参考文献:
1. Highly enantioselective Pd(II)-catalyzed Wacker-type
cyclization of 2-allylphenols by use of bisoxazoline ligands with axis-unfixed
biphenyl backbone Wang, Feijun et al, Tetrahedron Letters, 48(24), 4179-4182;
2007
2 Incorporation of a Phebox Rhodium Complex into apo-Myoglobin Affords a Stable
Organometallic Protein Showing Unprecedented Arrangement of the Complex in the
Cavity Satake, Yuh; Abe, Satoshi; Okazaki, Seiji; Ban, Noritaka; Hikage,
Tatsuo; Ueno, Takafumi; Nakajima, Hiroshi; Suzuki, Atsuo; Yamane, Takashi;
Nishiyama, Hisao; et al ,
Organometallics (2007), 26(20), 4904-4908.
3. Novel chiral bisoxazoline ligands with a biphenyl backbone:
preparation, complexation, and application in asymmetric catalytic reactions By
Imai, Yoshitane; Zhang, Wanbin; Kida, Toshiyuki; Nakatsuji, Yohji; Ikeda, Isao
,Journal of Organic Chemistry (2000), 65(11), 3326-3333.
4. Rhodium(III) and Rhodium(II) Complexes of Novel Bis(oxazoline) Pincer
Ligands Gerisch, Michael; Krumper, Jennifer R.; Bergman, Robert G.; Tilley, T.
Don,Organometallics (2003), 22(1), 47-58。
三、发明内容
本发明旨在提供一种Pd-N金属有机配合物以应用于催化领域,所要解决的技术问题遴选邻遴选相应的原料并建立相应的方法合成手性催化剂。
本发明所称的手性钯氮配合物是由以下化学式(I)所示的配合物:
化学名称:双{[1,4-(4S)-二异丙基-2-噁唑啉基苯]氯化钯}配合物,简称配合物(I)。
本手性配合物(I)的合成方法包括反应、分离和纯化,其特征是由1,4-
二氰基苯39.2mmol和L-缬氨醇16.2075g在无水无氧条件下和催化剂无水ZnCl2(26.4
mol%)于氯苯溶剂中回流反应60小时,然后分离、纯化,反应结束后脱去氯苯,将粗产品用石油醚/ 二氯甲烷(4:1)柱层析,得白色噁唑啉晶体,再按照噁唑啉与氯化钯摩尔比0.7:1,以氯苯为溶剂反应,用三氯甲烷、乙醇及正己烷进行重结晶,得红褐色双噁唑啉氯化钯配合物单晶。
该手性配合物在苯甲醛的亨利反应、腈硅化反应及Baylis-Hillman反应中显示一定的催化性能,其转化率分别达67.1%,80.1%,
36%。
四、附图说明
图1是配合物 (I) 的单晶衍射图。
五、具体实施方式
(一)手性配合物的制备
1.[1,4-(4R)-
二异丙基-
2
-噁唑啉基
]
苯的制备
在100mL两口瓶中,无水无氧条件下,加入无水ZnCl21.4054g(mmol),40ml氯苯, 1,4-二氰基苯5.0236g(50.75mmol),
L-缬氨醇
16.2075g,将混合物在高温下回流60h,停止反应,减压以除去溶剂, ,将剩余物用水溶解,并用CHCl3(20mLx2)萃取,有机相用无水硫酸钠干燥,旋转除去溶剂,将粗产品用石油醚/ 二氯甲烷(4:1)柱层析,得浅绿色粘稠状液体, 产率52%;白色晶体, 熔:48-50ºC,[a]5 D=+111.9º (c=0.429,CHCl3); 1HNMR
(500MHz,CDCl3, 27℃), δ(ppm)=7.97(s,4H), 4.39~4.43(t,
3.18Hz, 1H), 4.09~ 4.15(m,
2H),1.85~1.86(m, 1H), (d, J= 6.24Hz, 6H), 0.86~0.96(d, J=6.24Hz, 6H).13CNMR 18.13, 19.03,
32.85, 70.26, 72.76, 128.10, 128.16, 130.32, 162.82. IR:3273, 2976, 2960, 2932,
2889, 2869, 1643, 1512, 1469, 1408, 1382, 1366, 1350, 1320, 1296, 1276,
1214,1180, 1108, 1077, 1047,1014, 971, 955, 900, 891, 838, 726, 698, 675, 659,
540.HRMS(EI): m/z (%): calcd for C18H24N2O2:
300.1838; found: 300.1833。
双
{[1,4-(4S)-
二异丙基-
2
-噁唑啉基苯
]
氯化钯
}
配合物的制备
100mL两口瓶中,无水无氧条件下,加入氯化钯1.5603g (4.92mmol), 1,4-(4R)-二异丙基-2-噁唑啉基苯
1,.0435g (3..48mmol),氯苯30mL将混合物在高温下回流48h,停止反应,减压以除去溶剂, ,将剩余物三氯甲烷及乙醇溶解,自然挥发,得红褐色配合物得晶体,产率:82%;m.p.: >200°C,
[a]5 D=+514.2º
(c=0.0564, CH3OH):1HNMR
(600MHz,CDCl3, 27℃), δ(ppm)=8.86(s, 4H), 4.56-4.64(m, 4H), 7.10-7.35(m, 6H), 5.57(t, J=0.6Hz, 1H), 5.22(t, J=0.6Hz,1H),
4.97(t, J=0.3Hz, 1H), 4.46-4.48(m, 2H), 2.96-2.98(m, 2H), 1.06-1.12(dd,J=6.6,
7.2Hz, 12H); 13CNMR:168.7,
132.8, 75.2, 72.5, 33.5, 21.5, 18.7; 元素分析C36H50N4Cl4O5Pd2
实测值:C: 44.42%, H,5.18%, N, 5.76%;计算值:C:44.31%, H,5.14 %, N,5.55%;IR:3487,
3049, 2957, 2929,2872, 1642,
1609, 1572, 1509, 1480, 1464, 1416, 1379, 1331, 1288, 1246, 1178, 1141, 1123,
1099, 1045, 1018, 959, 933, 899, 854, 804, 770, 722, 693, 438;
配合物(I)晶体数据如下:
经验式
C36H50Cl4 N4O5 Pd2
分子量
973.40
温度
133(2) K
波长
0.71073Å
晶系, 空间群 单斜晶系, P2(1)
晶胞参数
a = 11.4699(8) Å α = 90 °.
b = 13.8149(9)Å β =
92.0580(10)°
c = 13.0964(9) Å γ = 90 °.
体积
2073.9(2)A^3
电荷密度
2, 1.559Mg/m^3
吸收 校正参数 1.169
mm^-1
单胞内的电子数目
988
晶体大小
0.176x 0.134x 0.112 mm
Theta 角的范围
1.777 to 26.000
HKL的指标收集范围
-14<=h<=14, -14<=k<17, -16<=l<=16
收集/独立衍射数据
15263/ 6933 [R(int) = 0.0323]
theta = 30.5的数据完整度
99.9%
吸收校正的方法
多层扫描
最大最小的透过率
0.7456 and 0.6960
精修使用的方法
F^2 的矩阵最小二乘法
数据数目/使用限制的数目/参数数目
6933/27/468
精修使用的方法 1.025
衍射点的一致性因子
R1 = 0.0324,wR2= 0.0753
可观察衍射的吻合因子
R1 = 0.0386, wR2 = 0.0785
绝对构型参数
-0.06(2)
差值傅里叶图上的最大峰顶和峰谷
0.863 and -0.607e.A^-3
晶体典型的键长数据:
Pd(1)-N(1)
2.005(6)
Pd(1)-N(4)
2.013(5)
Pd(1)-Cl(1)
2.2905(16)
Pd(1)-Cl(2)
2.2914(18)
Pd(2)-N(3)
2.013(5)
Pd(2)-N(2)
2.014(4)
Pd(2)-Cl(3)
2.2903(16)
Pd(2)-Cl(4)
2.2969(17)
晶体典型的键角数据:
N(1)-Pd(1)-N(4)
175.4(2)
N(1)-Pd(1)-Cl(1)
92.0(2)
N(4)-Pd(1)-Cl(1)
88.49(15)
N(1)-Pd(1)-Cl(2)
87.0(2)
N(4)-Pd(1)-Cl(2)
92.55(15)
Cl(1)-Pd(1)-Cl(2)
178.71(8)
N(3)-Pd(2)-N(2)
173.7(2)
N(3)-Pd(2)-Cl(3)
87.10(15)
N(2)-Pd(2)-Cl(3)
91.30(15)
N(3)-Pd(2)-Cl(4)
92.49(15)
N(2)-Pd(2)-Cl(4)
89.30(15)
Cl(3)-Pd(2)-Cl(4)
178.16(8)
C(1)-N(1)-C(3)
108.7(6)
C(1)-N(1)-Pd(1)
133.5(5)
C(3)-N(1)-Pd(1)
117.4(5)
C(13)-N(2)-C(15)
109.4(5)
C(13)-N(2)-Pd(2)
130.5(5)
C(15)-N(2)-Pd(2)
120.0(4)
C(19)-N(3)-C(21)
109.3(5)
C(19)-N(3)-Pd(2)
133.3(5)
C(21)-N(3)-Pd(2)
117.3(4)
C(31)-N(4)-C(33)
107.6(5)
C(31)-N(4)-Pd(1)
132.6(5)
C(33)-N(4)-Pd(1)
119.6(4)
C(1)-O(1)-C(2)
106.0(7)
C(13)-O(2)-C(14)
106.8(5)
C(19)-O(3)-C(20)
106.7(5)
C(31)-O(4)-C(32)
107.2(5)
(二)、亨利反应应用
1.E-
β
-
硝基苯乙烯的制备
取0.10mmol配合物(I)(催化用量为10%)于25mL的小烧瓶中,加入2毫升的四氢呋喃溶液,然后,向上述溶液中加入0.1mL的苯甲醛与0.5mL的硝基甲烷,常温搅拌,反应72小时,用石油醚/二氯甲烷淋洗,进行柱层析, 产率 67.1 %. 1HNMR
(300MHz, CDCl3), 8.00 (d, J=23Hz, 1H), 7.47~7.63 (m, 6H)。
(三)、腈硅化反应应用
2-
苯基
-2-
(三甲硅氧基)乙腈的制备
0.10mmol化合物I, 苯甲醛0.1mL,
TMSCN 0.3 ml (3.3mmol) 相继在20~30˚C下加入,72h 后, 加入水淬灭经柱层后(石油醚/二氯甲烷:5/1),得无色油状液体, 转化率:80.1%, 1HNMR (300MHz, CDCl3)
7.56–7.59 (m, 0.9 Hz, 2H), 7.31–7.34 (m, 3H), 5.43 (s, 1H), 0.16 (s, 9H). 13C
NMR (75 MHz, CDCl3) 136.1, 128.8(x2), 126.2(x2), 119.1, 63.5,
-0.39(x3)。
(3)Baylis-Hillman反应应用
取0.10mmol的配合物I(催化用量为10%)于25mL的小烧瓶中,加入2毫升的二氯甲烷溶液,然后,向上述溶液中加入0.1mL的苯甲醛与0.5mL丙烯酸甲酯,常温搅拌,反应小72小时后,进行核磁分析,转化率:36 %; 1HNMR (300MHz, CDCl3)
7.20~7.41 (m, 5H, Ar-H), 6.30(s, 1H), 5.45
(s, 1H), 3.70(s, 3H), 3.15(s, 1H)。
Claims (4)
1.一种手性双噁唑啉钯配合物,其化学式如下:
(Ⅰ)。
2.权利要求1所述的手性噁唑啉配合物(I),在133(2)k温度下,牛津X-射线单晶衍射仪上,用经石墨单色器单色化的MoKα射线(λ=0.71073 Å)以ω-θ 扫描方式收集衍射数据,其特征在于晶体属单斜晶系,空间群 P2(1),晶胞参数:a = 11.4699(7)Å,α = 90 °;b = 13.8149(9) Å, β = 92.0580(10)°; c = 13.0964(9) Å, γ= 90 °。
3.权利要求1所述的配合物(I)的合成方法,包括反应、分离和纯化,其特征由1,4-二氰基苯39.2mmol和L-缬氨醇16.2075g在无水无氧条件下和催化剂无水ZnCl2(26.4 mol%)于氯苯溶剂中回流反应60小时,然后分离、纯化,反应结束后脱去氯苯,将粗产品用石油醚/ 二氯甲烷(4:1)柱层析,得白色噁唑啉晶体,再按照噁唑啉与氯化钯摩尔比0.7:1,以氯苯为溶剂反应,用三氯甲烷、乙醇及正己烷进行重结晶,得红褐色双噁唑啉氯化钯配合物单晶。
4.该手性配合物在苯甲醛的亨利反应、腈硅化反应及Baylis-Hillman反应中显示一定的催化性能,其转化率分别达67.1%,80.1%, 36.2%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510258705.8A CN104876970B (zh) | 2015-05-20 | 2015-05-20 | 一种手性双噁唑啉钯配合物晶体及合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510258705.8A CN104876970B (zh) | 2015-05-20 | 2015-05-20 | 一种手性双噁唑啉钯配合物晶体及合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104876970A true CN104876970A (zh) | 2015-09-02 |
CN104876970B CN104876970B (zh) | 2017-06-16 |
Family
ID=53944675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510258705.8A Active CN104876970B (zh) | 2015-05-20 | 2015-05-20 | 一种手性双噁唑啉钯配合物晶体及合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104876970B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106800576A (zh) * | 2017-01-19 | 2017-06-06 | 合肥祥晨化工有限公司 | 一种手性铂配合物晶体的制备及合成方法 |
CN110314165A (zh) * | 2019-07-16 | 2019-10-11 | 合肥工业大学 | 一种手性噁唑啉钯配合物晶体的用途 |
CN112480126A (zh) * | 2020-12-11 | 2021-03-12 | 合肥工业大学 | 一种5-烷基喹唑啉衍生物的制备及用途 |
CN114621295A (zh) * | 2022-03-23 | 2022-06-14 | 合肥工业大学智能制造技术研究院 | 一种手性噁唑啉钯配合物晶体及用途 |
CN114656417A (zh) * | 2022-04-08 | 2022-06-24 | 合肥工业大学智能制造技术研究院 | 一种手性噁唑啉的合成方法及用途 |
-
2015
- 2015-05-20 CN CN201510258705.8A patent/CN104876970B/zh active Active
Non-Patent Citations (2)
Title |
---|
CARSTEN BOLM ET AL.: "Synthesis of Optically Active Bis(2-oxazolines): Crystal Structure of a 1,2-Bis(2-oxazolinyl)benzene ZnC12 Complex", 《CHEM. BER.》 * |
MANABU HATANO ET AL.: "Design of Chiral Macrocyclic Complexes Based on trans-Chelation of n:n Metal-Bidentate P,N- or N,N-Ligands", 《CHEMISTRY LETTERS》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106800576A (zh) * | 2017-01-19 | 2017-06-06 | 合肥祥晨化工有限公司 | 一种手性铂配合物晶体的制备及合成方法 |
CN110314165A (zh) * | 2019-07-16 | 2019-10-11 | 合肥工业大学 | 一种手性噁唑啉钯配合物晶体的用途 |
CN110314165B (zh) * | 2019-07-16 | 2021-08-20 | 合肥工业大学 | 一种手性噁唑啉钯配合物晶体的用途 |
CN112480126A (zh) * | 2020-12-11 | 2021-03-12 | 合肥工业大学 | 一种5-烷基喹唑啉衍生物的制备及用途 |
CN114621295A (zh) * | 2022-03-23 | 2022-06-14 | 合肥工业大学智能制造技术研究院 | 一种手性噁唑啉钯配合物晶体及用途 |
CN114621295B (zh) * | 2022-03-23 | 2023-08-22 | 合肥工业大学智能制造技术研究院 | 一种手性噁唑啉钯配合物晶体及用途 |
CN114656417A (zh) * | 2022-04-08 | 2022-06-24 | 合肥工业大学智能制造技术研究院 | 一种手性噁唑啉的合成方法及用途 |
CN114656417B (zh) * | 2022-04-08 | 2023-10-13 | 合肥工业大学智能制造技术研究院 | 一种手性噁唑啉的合成方法及用途 |
Also Published As
Publication number | Publication date |
---|---|
CN104876970B (zh) | 2017-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104876970A (zh) | 一种手性双噁唑啉钯配合物晶体及合成方法 | |
CN102887912B (zh) | 一种手性锌配合物 | |
Wang et al. | Synthesis, structure, and catalytic activity of group 4 complexes with new chiral biaryl-based NO2 ligands | |
CN104628788A (zh) | 一种手性噁唑啉钯配合物及用途 | |
Arvidsson et al. | Rational Design of Chiral Lithium Amides for Asymmetric Alkylation Reactions—NMR Spectroscopic Studies of Mixed Lithium Amide/Alkyllithium Complexes | |
CN112321627B (zh) | 一种轴手性芳乙炔基硅烷化合物及其制备方法 | |
CN111187219A (zh) | 一种磺酰胺咪唑盐化合物及其制备方法和应用 | |
CN102010443B (zh) | 一种手性膦酰双胺噁唑啉铜配合物及其合成方法 | |
Zhao et al. | Nickel‐Catalyzed Intermolecular [3+ 2+ 2] and [2+ 2+ 2] Cocyclizations of Bicyclopropylidene and Alkynes | |
CN102070673B (zh) | 一种邻氨基苄胺镍配合物 | |
CN103193808B (zh) | 一种手性锌配合物 | |
CN105198935A (zh) | 一种手性噁唑啉钯配合物 | |
CN103232480B (zh) | 一种手性锌配合物 | |
CN102850383B (zh) | 一种手性锌配合物 | |
CN104496929B (zh) | 一种含氯仿结晶的手性锌配合物晶体及用途 | |
CN103012443B (zh) | 一种手性锌配合物 | |
AU2021102174A4 (en) | Preparation and application of nitrogenous coordination ruthenium carbene catalyst | |
CN103570765B (zh) | 一种手性噁唑啉锰配合物晶体及其合成方法 | |
CN102153483B (zh) | 轴手性邻二胺化合物及其制备方法 | |
CN102875416B (zh) | 一种手性化合物 | |
CN105218473A (zh) | 一种含甲醇结晶的手性锌配合物 | |
CN102627616B (zh) | 一种手性锌配合物 | |
CN104327104A (zh) | 一种同质异晶手性锌配合物 | |
CN104327025A (zh) | 一种4-芳基萘内酯类衍生物的制备方法 | |
CN105884724B (zh) | 一种苯并呋喃类化合物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |